| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/29/2008 | US7364725 Endothelial cells engineered to express or overexpress fibulin-5 and a growth factor |
| 04/29/2008 | US7364724 Recombinant super-compound interferon |
| 04/29/2008 | CA2370098C Human beta-trcp protein |
| 04/29/2008 | CA2326283C Brassica napus with early maturity (early napus) and resistance to an ahas-inhibitor herbicide |
| 04/29/2008 | CA2315546C Constitutive maize promoters |
| 04/29/2008 | CA2285136C Coccidiosis vaccines |
| 04/29/2008 | CA2259960C Down-regulation of dna repair to enhance sensitivity to p53-mediated suppression |
| 04/29/2008 | CA2177952C Nucleosides and oligonucleotides containing boron clusters |
| 04/29/2008 | CA2120353C Cell cycle controlling compositions and methods of using same |
| 04/29/2008 | CA2024487C Polygalacturonase encoding fungal expression system |
| 04/24/2008 | WO2008049085A1 Antisense compounds |
| 04/24/2008 | WO2008049078A1 Nicked or gapped nucleic acid molecules and uses thereof |
| 04/24/2008 | WO2008048984A2 Methods and compositions for preparing a universal influenza vaccine |
| 04/24/2008 | WO2008048964A2 Methods and compositions for improving plant health |
| 04/24/2008 | WO2008048871A2 Cynomolgus il-13 mutein proteins, antibodies, compositions, methods and uses |
| 04/24/2008 | WO2008048407A2 Expression of streptomyces subtilisin inhibitor (ssi) proteins in bacillus and streptomyces sp. |
| 04/24/2008 | WO2008048392A1 Multiple mutation variants of serine protease |
| 04/24/2008 | WO2008048378A2 Kex2 cleavage regions of recombinant fusion proteins |
| 04/24/2008 | WO2008048344A2 Bacillus anthracis antigens, vaccine compositions, and related methods |
| 04/24/2008 | WO2008048306A2 Influenza a virus vaccines and inhibitors |
| 04/24/2008 | WO2008048037A1 A novel vector and expression cell line for mass production of recombinant protein and a process of producing recombinant protein using same |
| 04/24/2008 | WO2008047950A1 Environmental stress-responding promoter, and tissue-specific gene expression method using the same |
| 04/24/2008 | WO2008047947A1 Method for determining effect of cisplatin administration and kit for determining effect of cisplatin administration |
| 04/24/2008 | WO2008047936A1 LYTIC ENZYME INHIBITOR, LYSIS INHIBITOR, INHIBITOR OF DEGRADATION OF POLY-γ-GLUTAMIC ACID, AND METHOD FOR PRODUCTION OF POLY-γ-GLUTAMIC ACID |
| 04/24/2008 | WO2008047925A1 Pharmaceutical composition comprising anti-hb-egf antibody as active ingredient |
| 04/24/2008 | WO2008047914A1 Cancer therapeutic agent comprising anti-hb-egf antibody as active ingredient |
| 04/24/2008 | WO2008047904A1 Therapeutic agent for occlusive peripheral vascular disease, and use thereof |
| 04/24/2008 | WO2008047824A1 Method for determining presence or absence diabetes |
| 04/24/2008 | WO2008047821A1 Fused heterocyclic compound |
| 04/24/2008 | WO2008047819A1 Novel ester hydrolase, gene encoding the same, and use thereof |
| 04/24/2008 | WO2008047802A1 D-serine dehydratase and use thereof |
| 04/24/2008 | WO2008047723A1 Diagnosis and treatment of cancer using anti-ereg antibody |
| 04/24/2008 | WO2008047656A1 Method for production of l-amino acid |
| 04/24/2008 | WO2008047480A1 Method for control of distribution of mutation sites in variable region of antibody gene |
| 04/24/2008 | WO2008047473A1 Peptide vaccines for cancers expressing mphosph1 or depdc1 polypeptides |
| 04/24/2008 | WO2008047227A2 Method of assaying hiv-1 tropism for ccr5 and/or cxcr4 co-receptor and/or susceptibility to entry inhibitors |
| 04/24/2008 | WO2008047067A1 Treatment of inflammatory disease |
| 04/24/2008 | WO2008046943A1 Transposon hsmar2 and use thereof in the generation of vectors that can be used in somatic gene therapy |
| 04/24/2008 | WO2008046855A1 Glucanotransferase |
| 04/24/2008 | WO2008046602A2 2'-terminator related pyrophosphorolysis activated polymerization |
| 04/24/2008 | WO2008046256A1 Haemocoagulase |
| 04/24/2008 | WO2008046251A1 Fusion proteins containing n domain of human calreticulin and human papillomavirus type 16 e6 or e7 and uses thereof |
| 04/24/2008 | WO2008046189A1 Proteins involved in after-cooking darkening in potatoes |
| 04/24/2008 | WO2008046182A1 Stroma derived predictor of breast cancer |
| 04/24/2008 | WO2008029085A3 Polymerase |
| 04/24/2008 | WO2008028661A3 Potexvirus- derived replicon |
| 04/24/2008 | WO2008027592A9 Phased small rnas |
| 04/24/2008 | WO2008027558A3 Iterative nucleic acid assembly using activation of vector-encoded traits |
| 04/24/2008 | WO2008025711A3 Method for increasing resistance to pathogens in transgenic plants |
| 04/24/2008 | WO2008024372A3 Pullulanase variants with increased productivity |
| 04/24/2008 | WO2008021412A3 Interferon beta and transferrin fusion proteins |
| 04/24/2008 | WO2008015425A3 Mhc oligomers, components thereof, and methods of making the same |
| 04/24/2008 | WO2008012693A3 Recombinant mycobacterium strain expressing a mycobacterial fap protein under the control of a promoter active under hypoxia and its application for cancer therapy |
| 04/24/2008 | WO2008000881A9 Glycosylated human alpha interferon muteins, method for obtaining them and use |
| 04/24/2008 | WO2007147409A3 Ribozyme mediated stabilization of polynucleotides |
| 04/24/2008 | WO2007143168A3 High affinity antibodies to human il-6 receptor |
| 04/24/2008 | WO2007137075A3 Use of non-agrobacterium bacterial species for plant transformation |
| 04/24/2008 | WO2007132355A3 Compositions and methods for inhibiting viral adhesion |
| 04/24/2008 | WO2007127206A8 Biological systems input-output: response system and plant sentinels |
| 04/24/2008 | WO2007125127A3 Recombinantly prepared perlucin and use for preparing biomaterials |
| 04/24/2008 | WO2007124186A3 Expression control elements from the lemnaceae family |
| 04/24/2008 | WO2007112754A3 Pharmaceutical compositions comprising anti-mirna antisense oligonucleotides |
| 04/24/2008 | WO2007109677A3 A novel method of protecting islet cells from apoptosis during the donor harvesting process |
| 04/24/2008 | WO2007084926A3 Compositions and methods for humanization and optimization of n-glycans in plants |
| 04/24/2008 | WO2007084865A3 RNA INTERFERENCE MEDIATED INHIBITION OF B7-H1 GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 04/24/2008 | WO2002036740A8 Apoptosis-inducing ribozymes |
| 04/24/2008 | US20080098495 Disease resistant, enhanced shelf life, taste improved, stress tolerant eruca sativa |
| 04/24/2008 | US20080098490 Recombinant animal for use as bioreactor in production of human immunoglobulins |
| 04/24/2008 | US20080097092 Short interfering RNA sequences for use in treatment and prevention of diabetes, alzheimer's and cell proliferative disorders |
| 04/24/2008 | US20080097091 Short interfering RNA sequences for use in treatment and prevention of diabetes, alzheimer's and cell proliferative disorders |
| 04/24/2008 | US20080097090 Functional and hyperfunctional siRNA directed against Bcl-2 |
| 04/24/2008 | US20080097089 Short interfering RNA sequences for use as therapeutic tools in treatment of cancer, diabetes and nervous system disorders |
| 04/24/2008 | US20080097082 Nucleotide sequences coding recombinant protein for use in prevention and treatment of hyperphosphatemia |
| 04/24/2008 | US20080097080 Protein structure |
| 04/24/2008 | US20080096981 modulating activities associated with the IL-9 pathway for the treatment of atopic allergies like asthma; autoimmune diseases; new genes tightly expressed in association with an inflammatory response in the airways mediated by type 2 helper T-cells (TH). These genes have been designated TH2AF1 |
| 04/24/2008 | US20080096840 Gene expression inhibition by contacting cells which express kinase suppressor of Ras (KSR) with a nucleic acid which is complementary to a portion of the mRNA encoding KSR; antitumor, anticarcinogenic, antimetastasis and antiproliferative agents |
| 04/24/2008 | US20080096839 DNA vector encoding the RNA molecules and synthesized siRNA molecules; gene expression and viral replication inhibition |
| 04/24/2008 | US20080096835 Inhibitory oligonucleotides targeted to BCL-2 |
| 04/24/2008 | US20080096833 Diagnostic drugs and kits; coded for human proto-oncogene Pim-3, an antibody specific thereto; short interence RNA; genetic engineering |
| 04/24/2008 | US20080096821 Cytostatin II |
| 04/24/2008 | US20080096820 Prodomain modulators of ADAM 10 |
| 04/24/2008 | US20080096819 Amino acid substituted molecules |
| 04/24/2008 | US20080096818 administering polypeptides comprising beta amyloid fragments, to induce immunogenic response against amyloid deposits; prophylaxios and therapy of Alzheimer's disease |
| 04/24/2008 | US20080096813 Generation of potent dominant negative transcriptional inhibitors |
| 04/24/2008 | US20080096806 Compositions and methods for inhibiting microbial adhesion |
| 04/24/2008 | US20080096768 Epigenetic sequences for esophageal adenocarcinoma |
| 04/24/2008 | US20080096279 Expression vector comprising reporter enzyme for enhanced expression in microorganism; improving heterologouus gene expression in host cells |
| 04/24/2008 | US20080096278 Using aldehyde dehydrogenase as tool to activate the rice tungro bacilliform virus (RTBV) promoter in vivo; enhancing heterologus gene expression |
| 04/24/2008 | US20080096277 Expession vector comprising nucleotide sequences which code and enhance prolamin polypeptide transcription and RNA interfereing sequence which decrease expression of preferential storage proteins in seeds |
| 04/24/2008 | US20080096276 Expression vector comprising nucleotide sequences coding undecaprenyl diphosphate and dehydrodolichyl diphosphate synthases for use as tool in enhancing plant defenses |
| 04/24/2008 | US20080096274 Recombinant alphavirus vectors and methods of using same |
| 04/24/2008 | US20080096263 Recombinant Parainfluenza Virus Expression Systems And Vaccines Comprising Heterologous Antigens Derived From Respiratory Syncytial Virus |
| 04/24/2008 | US20080096254 Process for producing alpha1,4-galactosyltransferase and galactose-containing complex carbohydrate |
| 04/24/2008 | US20080096253 Methods of making nanotechnological and macromolecular biomimetic structures |
| 04/24/2008 | US20080096250 Expression vector comprising nucleotide sequences coding inflammatory response polypeptide for use in treatment and prevention of inflammation |
| 04/24/2008 | US20080096249 Agarase and gene thereof |
| 04/24/2008 | US20080096248 Grampositive bacterial polypeptide comprising toxin translocation domain for use as therapeutic targeting tools in cosmetic and the treatment of nervous system and nervous system disorders |
| 04/24/2008 | US20080096247 Nucleic acids encoding duramycin |
| 04/24/2008 | US20080096245 Cystatin-based peptide tags for the expression and purification of bioactive peptides |
| 04/24/2008 | US20080096244 High substrate specificity; vectors, host cells; heat resistance; electrophoresis |